| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.0002 |